Pear Therapeutics

Pear Therapeutics

Pear Therapeutics

Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need.
Type
B2c
Founded
2013
Raised
$234M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$80,000,000
Venture capital (Series D) - 2020
Temasek Holdings Pilot House Ventures Novartis +7
$64,000,000
Venture capital (Series C) - 2019
Temasek Holdings Novartis EDBI +9
Team Size
10+
Employees
$80,000,000 Venture capital (Series D)
MedCity News , Pulse 2.0

Pear Therapeutics raises $80M in push for reimbursement

the home of AI info

Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutic and Digital ...

$64,000,000 Venture capital (Series C)
PE HUB

Pear Therapeutics locks in $64 mln Series C

$50,000,000 Venture capital (Series B)
PE HUB

| PEAR Therapeutics scores $50 mln Series B

$20,000,000 Venture capital
VentureWire , FinSMEs

The Daily Startup: Pear Therapeutics Aims for Digital Substance-Abuse Treatment

Funding
$20,000,000 Venture capital (Series UNDISCLOSED)
PRWeb

Digital Therapeutics Pioneer Pear Therapeutics Raises $20M